According to a University of Oregon study.

In the December issue of the history of the American Thoracic Culture It was published. The study found premature infants are in elevated risk for contracting bronchopulmonary dysplasia, a chronic respiratory condition affecting infants born less than 28 weeks of age mainly. BPD primarily impacts preterm infants who receive oxygen therapy to help them breathe. The bigger levels of oxygen, along with the improved pressure from the ventilator used for treatment, can result in tissue scarring within their lungs in addition to other problems from an early on birth. Research offers indicated that infants with BPD are at a higher risk for the next advancement of chronic obstructive pulmonary disease, a progressive disease that means it is harder to breathe.Regarding antioxidant supplementation, our trial showed no effect overall or in virtually any subgroup. This finding might reflect the real insufficient usefulness of antioxidants; alternatively, it might be due to the characteristics of the analysis population or even to the dosage and method of administration in this trial. The laboratory substudy of UNITED STATES patients didn’t reveal the selenium insufficiency consistently seen in European and South American trials of selenium position in critically ill and healthful individuals.16,17 These differences may reflect the considerable depletion of selenium in soil seen in parts of Europe but not throughout North America.18 We might possess prescribed an insufficient dose of selenium or used an ineffective dosing plan, since a higher-than-normal level of selenium in the blood vessels may be associated with the best outcome19 and a short bolus of selenium may have been more effective compared to the continuous administration we used.20 The strengths of the scholarly study are the randomized and blinded style, rigorous dedication and adjudication of infection, and intention-to-treat analysis, all of which augment the inner validity of the trial.